T0	Participants 64 101	Women with Polycystic Ovary Syndrome:
T1	Participants 310 354	women with polycystic ovary syndrome (PCOS).
T2	Participants 433 467	64 women with PCOS were randomized
T3	Participants 1599 1620	supplementation among